Problem: Our client launched a new product in the U.S. market, but initial adoption rates were disappointingly low. Physicians, who were eager to incorporate this innovative product into their practice, hesitated to prescribe from the complexity…
Metastatic castration-resistant prostate cancer (mCRPC) is an incurable condition associated with poor prognosis and reduced quality of life. Historically, treatment options were limited, and despite recent advancements, the five-year survival rate for metastatic prostate cancer remains…
For manufacturers of rare disease therapies, selecting the right specialty pharmacy model is a crucial decision that directly impacts patient access, adherence and overall brand success. An exclusive specialty pharmacy model offers distinct advantages, including streamlined…
Traditional commercialization strategies that once fueled massive growth and profitability are no longer viable in today’s complex and competitive market. High SG&A costs without resulting revenue, patent cliffs, rising patient acquisition costs, convoluted supply chain management,…
Company recognized in 2025 for AI-Powered HCP Panels Used for Sales Representative Training Innovation is in the lifeblood of EVERSANA. And so, when the 2025 AI Excellence Awards winners were announced, it was not surprising that…
In today’s fiscal environment, efficient capital allocation is crucial for success. Biopharma companies can take advantage of new approaches to commercialization to dramatically reduce the capital burden to launch their products. Building Your Own Commercial Infrastructure…
In the pharmaceutical industry, maintaining asset value is challenging. Traditionally, companies either licensed their products or built their own commercial setup, each option with its own risks. But what if there were a powerful alternative that…
A Rare Diagnosis and the Start of a Family’s Courageous Journey For families navigating the complexities of a rare disease diagnosis, the path can be filled with uncertainty, challenges and moments of profound resilience. One such…
Artificial intelligence (AI) is transforming the sales landscape, offering innovative ways to boost efficiency, enhance decision-making and drive revenue growth. With AI adoption in sales ranking among the top three functions across industries, organizations must leverage…
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…